Schroder Investment Management Group decreased its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) by 25.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 44,326 shares of the company’s stock after selling 14,850 shares during the period. Schroder Investment […]
Shaker Investments LLC OH raised its position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) by 1.1% in the fourth quarter, HoldingsChannel reports. The fund owned 81,287 shares of the company’s stock after purchasing an additional 888 shares during the quarter. Amphastar Pharmaceuticals makes up approximately 1.4% of Shaker Investments LLC OH’s holdings, making the […]
StockNews.com assumed coverage on shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Rating) in a research note released on Thursday. The firm issued a strong-buy rating on the stock. Amphastar Pharmaceuticals Stock Up 0.7 % AMPH stock opened at $44.16 on Thursday. Amphastar Pharmaceuticals has a fifty-two week low of $26.76 and a fifty-two week high […]
StockNews.com initiated coverage on shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Rating) in a report released on Thursday morning. The firm issued a strong-buy rating on the stock. Amphastar Pharmaceuticals Trading Up 0.7 % Shares of AMPH opened at $44.16 on Thursday. The firm has a 50 day moving average price of $39.16 and a […]
Research analysts at StockNews.com started coverage on shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Rating) in a research report issued to clients and investors on Thursday. The brokerage set a “strong-buy” rating on the stock. Amphastar Pharmaceuticals Price Performance Shares of AMPH opened at $44.16 on Thursday. The company has a market capitalization of $2.13 […]